POSA241 Diabetic Macular Edema Patients Treated with ANTI-VEGF Intravitreal Injections in Portugal: An Administrative Database Study from 2013 to 2018

Diabetic macular edema (DME) is the leading cause of vision loss in people with diabetes and preserve the vision of more than one million Portuguese with diabetes is a major challenge. This study aimed to analyze the number of patients with DME treated with anti-VEGF drugs in the Portuguese national health service (NHS) and assess regional differences.